Aytu BioPharma, Inc. (AYTU) NASDAQ
2.10
-0.05(-2.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.69M |
| Enterprise Value | 5.67M |
| P/E Ratio | -0.65 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.3 |
| Price/Book Ratio | 0.63 |
| Enterprise/Revenue | 0.23 |
| Enterprise/EBITDA | -0.5 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.6 |
| Operating Margin | -0.27 |
Management Effectiveness
| Return On Assets | -0.3 |
| Return On Equity | -1.49 |
Income Statement
| Revenue | 66.38M |
| Revenue/Share | 5.38 |
| Gross Profit | 45.83M |
| EBITDA | -4.67M |
| Net Income | -13.56M |
| Diluted EPS | -2.16 |
Balance Sheet
| Total Cash | 26.72M |
| Total Cash/Share | 2.54 |
| Total Debt | 22.94M |
| Total Debt/Equity | 0.65 |
| Current Ratio | 1.12 |
| Book Value Per Share | 3.34 |
Price History
| 52-Week Change | 17.98 |
| 52-Week High | 3.07 |
| 52-Week Low | 1.46 |
| Moving Average 50 Days | 2.48 |
| Moving Average 200 Days | 2.38 |
Statistics
| Average Volume | 44,887 |
| Shares Outstanding | 8.1M |
| % Held by Institutions | 39.38 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 06, 2023 |
